Mangoceuticals (MGRX) Income Statement: Revenue & Earnings

Mangoceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Mangoceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.62	0.73	0.01	0.00
Cost of Revenue	0.24	0.30	0.00	0.00
Gross Profit	0.38	0.43	0.00	0.00
Operating Expenses
Research & Development	0.00	0.00	0.00	0.00
Selling, General & Administrative	7.90	8.55	2.00	0.07
Operating Expenses	9.07	9.65	2.00	0.07
Operating Income	-8.69	-9.22	-1.99	-0.07
Other Income/Expense
Interest Income	0.00	0.01	0.00	0.00
Interest Expense	0.01	0.00	-0.01	0.00
Other Income/Expense	-0.74	0.01	0.00	0.00
Income
Income Before Tax	-8.71	-9.21	-2.00	-0.07
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-8.71	-9.21	-2.00	-0.07
Net Income - Continuous Operations	-8.71	-9.21	-2.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-7.90	-9.13	-1.99	0.00
EBIT	-8.69	-9.21	-1.99	-0.07
Depreciation & Amortization	0.72	0.08	0.00	0.00
Earnings Per Share
Basic EPS	-5.00	-9.00	-3.00	-
Diluted EPS	-5.00	-9.00	-3.00	-
Basic Shares Outstanding	1.98	1.07	0.72	0.53
Diluted Shares Outstanding	1.98	1.07	0.72	0.53